Dorward J, Masombuka X, Lewis L, Pastellides C, et al. Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa. Clin Infect Dis 2026 Mar 4:ciag155. doi: 10.1093.
PMID: 41787927